Skip to main content

Date last updated: 02/23/2021

 

General comments:  We provide these summary data in the spirit of transparency and open data sharing.  Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.

 

Total number of cases reported: 5,329

 

Report a Case

Cases reported by country*

countryN
United States1976
United Arab Emirates20
Afghanistan1
Argentina72
Austria89
Australia11
Belgium172
Bulgaria20
Bahrain1
Saint Barthélemy1
Bolivia, Plurinational State of1
Brazil121
Canada119
Switzerland42
Chile22
China1
Colombia3
Costa Rica4
Cyprus4
Czech Republic53
Germany190
Dominican Republic15
Ecuador2
Egypt2
Spain364
Finland7
France125
United Kingdom214
Greece28
Croatia15
Hungary6
Ireland74
Israel43
India34
Iran, Islamic Republic of58
Italy186
Japan38
Korea, Republic of3
Kuwait20
Kazakhstan1
Luxembourg1
Latvia4
Morocco8
Mexico13
Malaysia2
Netherlands229
Norway16
New Zealand1
Peru9
Philippines2
Poland36
Portugal83
Paraguay1
Qatar2
Romania15
Serbia15
Russian Federation330
Saudi Arabia14
Sweden2
Slovenia15
Slovakia45
Tunisia2
Turkey111
Ukraine1
Uruguay1
Venezuela, Bolivarian Republic of4
South Africa17
Missing65

* Countries not included in this table have not reported any cases to SECURE-IBD

 

Cases reported by state (U.S. only)*

stateN
ALABAMA24
ARIZONA19
ARKANSAS10
CALIFORNIA113
COLORADO15
CONNECTICUT26
DELAWARE4
DISTRICT OF COLUMBIA10
FLORIDA72
GEORGIA52
IDAHO3
ILLINOIS185
INDIANA14
IOWA21
KANSAS15
KENTUCKY13
LOUISIANA43
MAINE2
MARYLAND32
MASSACHUSETTS64
MICHIGAN37
MINNESOTA65
MISSISSIPPI27
MISSOURI44
MONTANA9
NEBRASKA46
NEVADA6
NEW HAMPSHIRE3
NEW JERSEY68
NEW MEXICO1
NEW YORK284
NORTH CAROLINA61
NORTH DAKOTA3
OHIO131
OKLAHOMA8
OREGON7
PENNSYLVANIA87
RHODE ISLAND19
SOUTH CAROLINA17
SOUTH DAKOTA3
TENNESSEE60
TEXAS86
UTAH19
VERMONT2
VIRGINIA29
WASHINGTON33
WEST VIRGINIA1
WISCONSIN60
GUAM2
PUERTO RICO2
NA55

* States not included in this table have not reported any cases to SECURE-IBD

 

Cases and outcomes by patient characteristics

CharacteristicTotal NOutpatient only (n, %)Hospitalized (n, %)ICU (n, %)Ventilator (n, %)Death (n, %)ICU/Ventilator/Death (n, %)
Overall5,3294,41383%84616%1563%1202%852%2154%
Age
0-9 years 332988%39%26%26%00%26%
10-19 years 55452595%244%31%10%00%31%
20-29 years 1,1231,02091%908%40%10%10%50%
30-39 years 1,10797188%11711%141%71%30%151%
40-49 years 95480985%13814%222%162%30%243%
50-59 years 79361077%17722%354%314%111%456%
60-69 years 43126762%15335%4911%399%246%5713%
70-79 years 1849954%8144%2111%158%1810%3418%
>=80 years 1205848%5949%43%87%2420%2823%
Sex
Male 2,5632,06981%46318%813%632%582%1195%
Female 2,6842,27685%37214%723%542%271%933%
Other 3267%00%00%00%00%00%
Disease type
Crohn’s disease 3,0502,61286%40113%652%522%331%843%
Ulcerative Colitis/unspecified2,2441,77579%44020%894%663%512%1296%
IBD Disease
Activity
Remission2,9312,50886%40214%773%662%411%1074%
Mild1,14997885%16014%252%171%161%383%
Moderate/Severe1,00074174%24525%455%303%232%596%
Unknown24918675%3916%94%73%52%114%
Smoking
Current smoker20516681%3919%63%21%42%84%
Non-smoker5,1244,24783%80716%1503%1182%812%2074%
Comorbidities
03,7953,37489%37910%441%331%90%541%
11,06881676%23122%434%323%252%575%
228115856%11942%2810%259%176%4115%
3+1856535%11763%4122%3016%3418%6334%
IBD medication
Sulfasalazine/mesalamine1,5471,17976%35223%684%624%443%1006%
Budesonide 14210574%3625%75%43%43%96%
Oral/parenteral steroids 35021762%12736%3510%247%237%4613%
6MP/azathioprine monotherapy44034478%9321%225%143%82%286%
Methotrexate monotherapy433172%1126%12%12%25%37%
Anti-TNF without 6MP/AZA/MTX 1,7661,59390%1539%211%131%70%241%
Anti-TNF + 6MP/AZA/MTX 51442583%8416%143%92%51%173%
Anti-integrin 59650485%8214%193%102%71%254%
IL 12/23 inhibitor 50845289%449%61%61%31%82%
JAK inhibitor 847589%911%22%11%11%22%
Other IBD medication 16912775%3923%85%42%32%85%

*Medication categories are not mutually exclusive

 

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.